Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
- Posted on January 15, 2025
- By CNBC
- 1 Views
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the latter part of the year.
